Match the following clinical presentations in patients with advanced HIV/AIDS to their most appropriate definitive pharmacotherapy.
- CD4 cell count of , presenting with painless, progressive loss of vision. Fundoscopy reveals perivascular hemorrhages and fluffy white exudates.Intravitreal ganciclovir and systemic valganciclovir
- CD4 cell count of , presenting with a dry cough, dyspnea on exertion, bilateral ground-glass opacities on chest CT, and a of on room air.Intravenous trimethoprim-sulfamethoxazole and systemic corticosteroids
- CD4 cell count of , presenting with headache, confusion, new-onset seizures, and multiple ring-enhancing lesions on brain MRI.Oral sulfadiazine, pyrimethamine, and leucovorin
- CD4 cell count of , presenting with fever, night sweats, marked weight loss, and elevated alkaline phosphatase. Blood cultures grow acid-fast bacilli.Oral clarithromycin and ethambutol
Cevap
The correct pairings accurately match advanced HIV opportunistic infections with their definitive first-line therapies based on the clinical presentation, objective findings, and CD4 count thresholds.
Each clinical scenario describes a classic opportunistic infection associated with specific CD4 count thresholds in advanced HIV/AIDS, requiring a highly specific targeted antimicrobial regimen as per standard clinical guidelines.
Adım Adım Çözüm
Anahtar Kavram
Identifying and treating major opportunistic infections in advanced HIV/AIDS based on CD4 thresholds and characteristic clinical syndromes.